CEDRIC: Clopidogrel- Effects on Diameter Reduction and Intimal Hyperplasia in Long-term Follow up after Cardiac Transplantation.
Phase of Trial: Phase II/III
Latest Information Update: 17 Nov 2015
At a glance
- Drugs Clopidogrel (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis; Heart transplant rejection
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms CEDRIC
- 14 Nov 2015 Status changed from discontinued to completed as per European Clinical Trials Database record.
- 07 Nov 2015 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 11 Oct 2011 New trial record